503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-28.68%
Both yoy net incomes decline, with BB at -19.99%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
5.06%
Less D&A growth vs. BB's 23.80%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-181.06%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
3.60%
SBC growth of 3.60% while BB is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
617.63%
Well above BB's 750.27% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
203.04%
AR growth of 203.04% while BB is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-54.83%
Negative yoy usage while BB is 457.72%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-3.10%
Both negative yoy, with BB at -131.72%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
4.53%
Some CFO growth while BB is negative at -6.66%. John Neff would note a short-term liquidity lead over the competitor.
24.94%
CapEx growth well above BB's 22.13%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
100.00%
Acquisition growth of 100.00% while BB is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-78.34%
Both yoy lines negative, with BB at -169.63%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-29.18%
We reduce yoy sales while BB is 57.12%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
456.74%
Growth well above BB's 100.00%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-140.46%
Both yoy lines negative, with BB at -37.43%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
95.24%
Debt repayment growth of 95.24% while BB is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-19.72%
Both yoy lines negative, with BB at -57.61%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
99.36%
Buyback growth of 99.36% while BB is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.